​

Funding Round

Series C - Carrick Therapeutics

Series C - Carrick Therapeutics

Investment Firm

Overview

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Announced Date

Dec 01, 2022

Funding Type

Series C

Highlights

Location

Europe

Social

Investor Lead

Pfizer

Pfizer

Pfizer is a private_equity and venture firm.

Participant Investors

8

Investor Name
Participant InvestorCambridge Innovation Capital
Participant InvestorLightstone Ventures
Participant InvestorPfizer
Participant InvestorGoogle Ventures
Participant InvestorARCH Venture Partners

Round Details and Background

Carrick Therapeutics raised $60000000 on 2022-12-01 in Series C

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 01, 2022
Series C - Carrick Therapeutics
8-60.0M
Oct 03, 2016
Series A - Carrick Therapeutics
7-95.0M

Recent Activity

There is no recent news or activity for this profile.